Search

Purpose: To verify the affective feelings (AFs) and rating of perceived exertion (RPE) responses during a 10-km competitive head-to-head (HTH) running race and compare them with a time-trial (TT) running race. Methods: Fourteen male runners completed 2 × 10-km runs (TT and HTH) on different days. Speed, RPE, and AF were measured every 400 m. For pacing analysis, races were divided into the following 4 stages: first 400 m (F400), 401–5000 m (M1), 5001–9600 m (M2), and the last 400 m (final sprint). Results: Improvement of performance was observed (39:32 [02:41] min:s vs 40:28 [02:55] min:s; P = .03; effect size = −0.32) in HTH compared with TT. There were no differences in either pacing strategy or RPE between conditions. AFs were higher during the HTH, being different in M2 compared with TT (2.09 [1.81] vs 0.22 [2.25]; P = .02; effect size = 0.84). Conclusions: AFs are directly influenced by the presence of opponents during an HTH race, and a more positive AF could be involved in the dissociation between RPE and running speed and, consequently, the overall race performance.

Objectives: the aim of the present study was to verify the pacing strategy during a season of a Cross-Country Mountain Bike (XCO-MTB) and the effects of performance level, age and sex. Method: Overall, 802 paces in 4 age-sex categories were analyzed: male elite (EliteM; n = 272), female elite (EliteF; n = 170), male under-23 (U23M; n = 247) and female under-23 (U23F; n = 113). Races were divided into Initial Lap; middle one (Middle1); middle two (Middle2) and Final Lap. The athletes were divided into high performance (HP); intermediated performance (IP) and low performance (LP). The magnitude-based inference and the effect size were assessed to check the changes clinically important. Results: it was observed a similar fast-start strategy for all categories. Both HP EliteM and EliteF athletes showed higher speed in Final Lap than LP (EliteM - ES = 0.5; 90%CI -0.8 to -0.2; very likely and EliteF - ES = 1.0; 90%CI -1.4 to -0.6; almost certain). The U23F athletes showed higher speeds in Initial Lap than EliteF (ES = 0.21; 90%CI - 0.1 to 0.5; likely), however in Final Lap the speeds was lower in U23F (ES = 1; 90%CI -1.3 to -0.6; very likely). Conclusion: the fast-start strategy is typically used during a XCO-MTB race independently of performance level, age or sex. HP Elite athletes are able to maintain higher speeds in the Final Lap. U23F athletes used to do a more variable pacing strategy with more aggressive fast-start strategy and lower speed in Final Lap than EliteF.

Purpose: This study examined the relationships between the Yo-Yo Intermittent Recovery Test level 1 (Yo-Yo IR1) and resting heart rate variability (HRV) and submaximal 5ʹ-5ʹ test derived me...

do Carmo, EC, De Souza, EO, Roschel, H, Kobal, R, Ramos, H, Gil, S, and Tricoli, V. Self-selected rest interval improves vertical jump postactivation potentiation. J Strength Cond Res 35(1): 91-96, 2021-This study compared the effects of self-selected rest interval (SSRI) and fixed rest interval (FRI) strategies on postactivation potentiation (PAP) in countermovement jump (CMJ) performance. Twelve strength-trained men (age: 25.4 ± 3.6 years; body mass: 78.8 ± 10.5 kg; height: 175 ± 7.0 cm; half-squat 1 repetition maximum: 188.7 ± 33.4 kg) performed 3 experimental conditions: (a) FRI: CMJ test; 4-minute rest interval; 5 repetition maximum (5RM) back squat; 4-minute rest interval; and CMJ test, (b) SSRI: CMJ test; 4-minute rest interval; 5RM back squat; SSRI; and CMJ test, and (c) control: CMJ test; 8-minute rest interval and CMJ test. In SSRI, subjects were instructed to rest until they felt fully recovered and able to exercise at maximal intensity based on the perceived readiness scale. Significant changes in pre-post CMJ performance were observed in the SSRI condition (38.2 ± 4.6 cm vs. 40.5 ± 4.4 cm; p = 0.08; confidence interval [CI]: 0.72-3.82 cm; effect size [ES] = 0.93). There were significant differences in post-CMJ performance when SSRI was compared with FRI (40.5 ± 4.4 cm vs. 37.7 ± 5.1 cm; p = 0.02; CI: 0.43-5.08; ES = 1.13) and control (40.5 ± 4.4 cm vs. 37.4 ± 5.7 cm; p = 0.01; CI: 0.66-5.61; ES = 1.35). The average rest interval length for the SSRI condition was 5:57 ± 2:44 min:sec (CI: 4:24-7:30). Our results suggest that the use of SSRI was an efficient and practical strategy to elicit PAP on CMJ height in strength-trained individuals.

O treinamento físico aeróbio (TF) tem sido utilizado como um importante tratamento não farmacológico da hipertensão arterial (HA), uma vez que ele corrige a rarefação microvascular e reduz a pressão arterial. Estudos mostram que as anormalidades microvasculares estão diretamente associadas às alterações do fator de crescimento vascular endotelial (VEGF) e do VEGF receptor 2 (VEGFR2), bem como a um desequilíbrio da sinalização apoptótica na HA. Entretanto, pouco se conhece sobre os efeitos do TF sobre estes parâmetros na HA. Nós hipotetizamos que o TF recupere os fatores angiogênicos e promova um equilíbrio entre as proteínas anti e pró-apoptóticas da família Bcl-2 potencialmente, contribuindo para a revascularização e regressão da doença. Ratos espontaneamente hipertensos (SHR, n = 14) e Wistar Kyoto (WKY, n = 14) com 12 semanas de vida e divididos em quatro grupos: SHR, SHR treinado (SHR-T), WKY e WKY treinado (WKY-T) foram estudados. Como esperado, 10 semanas de TF foram efetivas em reduzir a pressão arterial em SHR-T. Além disso, o TF promoveu bradicardia de repouso nos grupos de animais treinados (WKY-T e SHR-T), sendo considerado como um importante marcador de TF aeróbio. O TF também corrigiu a rarefação capilar em SHR-T e esta resposta se deve em grande parte por uma recuperação dos níveis periféricos de VEGF e um aumento na expressão de VEGFR2. Em paralelo, foi observada uma normalização das vias apoptóticas, com aumento da expressão de proteínas antiapoptóticas (Bcl-2 e Bcl-x) e redução das pró-apoptóticas (Bad) acompanhada pela fosforilação de Bad. Estes resultados sugerem que o TF promove revascularização periférica na HA dependente de um fino balanço de reguladores positivos e negativos de angiogênese.

A number of theoretical models have been proposed in recent years to explain pacing strategies observed in individual competitive endurance events. These have typically related to the internal regulatory processes that inform the making of decisions relating to muscular work rate. Despite a substantial body of research which has investigated the influence of collective group dynamics on individual behaviors in various animal species, this issue has not been comprehensively studied in individual athletic events. This is somewhat surprising given that athletes often directly compete in close proximity to one another, and that collective behavior has also been observed in other human environments including pedestrian interactions and financial market trading. Whilst the reasons for adopting collective behavior are not fully understood, collective behavior is thought to result from individual agents following simple local rules that result in seemingly complex large systems that act to confer some biological advantage to the collective as a whole. Although such collective behaviors may generally be beneficial, competitive endurance events are complicated by the fact that increasing levels of physiological disruption as activity progresses may compromise the ability of some individuals to continue to interact with other group members. This could result in early fatigue and relative underperformance due to suboptimal utilization of physiological resources by some athletes. Alternatively, engagement with a collective behavior may benefit all due to a reduction in the complexity of decisions to be made and a subsequent reduction in cognitive loading and mental fatigue. This paper seeks evidence for collective behavior in previously published analyses of pacing behavior and proposes mechanisms through which it could potentially be either beneficial, or detrimental to individual performance. It concludes with suggestions for future research to enhance understanding of this phenomenon.

We evaluated the effects of swimming and anabolic steroids (AS) on ventricular function, collagen synthesis, and the local renin-angiotensin system in rats. Male Wistar rats were randomized into control (C), steroid (S; nandrolone decanoate; 5 mg/kg sc, 2×/wk), steroid + losartan (SL; 20 mg·kg−1·day−1), trained (T), trained + steroid (T+S), and trained + steroid + losartan (T+SL; n = 14/group) groups. Swimming was performed 5 times/wk for 10 wk. Serum testosterone increased in S and T+S. Resting heart rate was lower in T and T+S. Percent change in left ventricular (LV) weight-to-body weight ratio increased in S, T, and T+S. LV systolic pressure declined in S and T+S. LV contractility increased in T ( P < 0.05). LV relaxation increased in T ( P < 0.05). It was significantly lower in T+S compared with C. Collagen volumetric fraction (CVF) and hydroxyproline were higher in S and T+S than in C and T ( P < 0.05), and the CVF and LV hypertrophy were prevented by losartan treatment. LV-ANG I-converting enzyme activity increased (28%) in the S group (33%), and type III collagen synthesis increased (56%) in T+S but not in T group. A positive correlation existed between LV-ANG I-converting enzyme activity and collagen type III expression ( r2 = 0.88; P < 0.05, for all groups). The ANG II and angiotensin type 1a receptor expression increased in the S and T+S groups but not in T group. Supraphysiological doses of AS exacerbated the cardiac hypertrophy in exercise-trained rats. Exercise training associated with AS induces maladaptive remodeling and further deterioration in cardiac performance. Exercise training associated with AS causes loss of the beneficial effects in LV function induced by exercising. These results suggest that aerobic exercise plus AS increases cardiac collagen content associated with activation of the local renin-angiotensin system.

The aim of this study is to analyse the influence of performance level, age and gender on pacing during a 100-km ultramarathon. Results of a 100-km race incorporating the World Masters Championships were used to identify differences in relative speeds in each 10-km segment between participants finishing in the first, second, third and fourth quartiles of overall positions (Groups 1, 2, 3 and 4, respectively). Similar analyses were performed between the top and bottom 50% of finishers in each age category, as well as within male and female categories. Pacing varied between athletes achieving different absolute performance levels. Group 1 ran at significantly lower relative speeds than all other groups in the first three 10-km segments (all P < 0.01), and significantly higher relative speeds than Group 4 in the 6th and 10th (both P < 0.01), and Group 2 in the 8th (P = 0.04). Group 4 displayed significantly higher relative speeds than Group 2 and 3 in the first three segments (all P < 0.01). Overall strategies remained consistent across age categories, although a similar phenomenon was observed within each category whereby ‘top’ competitors displayed lower relative speeds than ‘bottom’ competitors in the early stages, but higher relative speeds in the later stages. Females showed lower relative starting speeds and higher finishing speeds than males. ‘Top’ and ‘bottom’ finishing males displayed differing strategies, but this was not the case within females. Although pacing remained consistent across age categories, it differed with level of performance within each, possibly suggesting strategies are anchored on direct competitors. Strategy differs between genders and differs depending on performance level achieved in males but not females.

Purpose: Cardiac aldosterone might be involved in the deleterious effects of nandrolone decanoate (ND) on the heart. Therefore, we investigated the involvement of cardiac aldosterone, by the pharmacological block of AT1 or mineralocorticoid receptors, on cardiac hypertrophy and fibrosis. Methods: Male Wistar rats were randomized into eight groups (n = 14 per group): Control (C), nandrolone decanoate (ND), trained (T), trained ND (TND), ND + losartan (ND + L), trained ND + losartan (TND + L), ND + spironolactone (ND + S), and trained ND + spironolactone (TND + S). ND (10 mg·kg-1·wk-1) was administered during 10 wk of swimming training (five times per week). Losartan (20 mg·kg-1·d-1) and spironolactone (10 mg·kg-1·d-1) were administered in drinking water. Results: Cardiac hypertrophy was increased 10% by using ND and 17% by ND plus training (P < 0.05). In both groups, there was an increase in the collagen volumetric fraction (CVF) and cardiac collagen type III expression (P < 0.05). The ND treatment increased left ventricle-angiotensin-converting enzyme I activity, AT1 receptor expression, aldosterone synthase (CYP11B2), and 11-s hydroxysteroid dehydrogenase 2 (11s-HSD2) gene expression and inflammatory markers, TGFs and osteopontin. Both losartan and spironolactone inhibited the increase of CVF and collagen type III. In addition, both treatments inhibited the increase in left ventricle-angiotensin-converting enzyme I activity, CYP11B2, 11s-HSD2, TGFs, and osteopontin induced by the ND treatment. Conclusions: We believe this is the first study to show the effects of ND on cardiac aldosterone. Our results suggest that these effects may be associated to TGFs and osteopontin. Thus, we conclude that the cardiac aldosterone has an important role on the deleterious effects on the heart induced by ND.